ASSOCIATIONS OF TRIGLYCERIDE-GLUCOSE-OBESITY COMPOSITE INDICES WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITY IN INDIVIDUALS WITH CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME STAGES 0–3 AND THEIR POTENTIAL INCREMENTAL VALUE BEYOND A PREVENT-VARIABLE-BASED MODEL

Descargar Publicación
¿Son los GLP-1 prácticos y seguros para los adolescentes con obesidad? The Lancet commission definition of clinical obesity: a multi-cohort cross-sectional analysis from early childhood to older age in seven high-income countries